Child Development Disorders, Pervasive Clinical Trial
Official title:
Randomized Trial of Parent Training for Young Children With Autism
The purpose of this 24 week study is to determine whether a new Parent Training program is effective in reducing disruptive behaviors in young children with pervasive developmental disorders.
Pervasive Developmental Disorders (PDDs) are a group of conditions that includes Autistic
Disorder, Asperger's disorder and so called Pervasive Developmental Disorder - Not Otherwise
Specified. Children with PDD show delays in speech and language and reduced social
interaction. Some children with PDD also have behavior problems, including defiance of
rules, aggression, and tantrums. The purpose of this study is to evaluate a new Parent
Training program designed to decrease these behavior problems and improve daily living
skills.
Following confirmation of eligibility, participants will be randomly assigned to receive
either Parent Training or a Psychoeducational Program. The Parent Training program involves
specific suggestions about how to deal with behavior problems. The Psychoeducational program
covers specific issues related to autism and parenting, including an co-occurring medical
conditions and treatment options.
Parents will attend up to 13 one-on-one sessions with a trained therapist over a 24-week
period. Participation in the study also involves 2 home visits and 6 monthly assessment
visits. The purpose of the assessment visits is to evaluate the child's response to
treatment. Evaluations will also be conducted at 3 and 6 months after completion of the
study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03222375 -
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
| Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
| Withdrawn |
NCT00376194 -
Mercury Chelation to Treat Autism
|
Phase 2 | |
| Completed |
NCT02153203 -
Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders
|
N/A | |
| Completed |
NCT02301195 -
Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder
|
N/A | |
| Completed |
NCT00453180 -
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
|
Phase 2 | |
| Completed |
NCT04475848 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
|
Phase 1 | |
| Terminated |
NCT01517126 -
Assessing Suicide Risk in Adolescents With Developmental Delays
|
||
| Completed |
NCT00080145 -
RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
|
N/A | |
| Completed |
NCT00166595 -
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
|
Phase 1/Phase 2 | |
| Completed |
NCT02124720 -
Using Mobile Technology to Reduce Stereotypy
|
N/A | |
| Completed |
NCT01731119 -
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
|
Phase 2 | |
| Completed |
NCT00147394 -
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
|
Phase 1 | |
| Completed |
NCT01921244 -
Shared Decision Making to Improve Care and Outcomes for Children With Autism
|
N/A | |
| Completed |
NCT05688319 -
Effect of Problem-Solving Training
|
N/A | |
| Terminated |
NCT00445471 -
A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
|
N/A | |
| Active, not recruiting |
NCT00110708 -
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
|
Phase 2 |